Long-lasting alterations in 5-HT2A receptor after a binge regimen of methamphetamine in mice
Hong‐yi Chiu, Ming‐huan Chan, Mei-Yi Lee, Shao‐tsu Chen, Zih-Yi Zhan, Hwei‐hsien Chen
The International Journal of Neuropsychopharmacology April 24, 2014 DOI: 10.1017/s1461145714000455 via OpenAlex
Summary
AI-generated from the abstractA single-day 'binge' dosing regimen of methamphetamine in male mice impaired recognition memory, reduced social behaviors, and increased sensitivity to a hallucinogenic drug that activates serotonin 5-HT2A receptors. The heightened behavioral, molecular, and electrophysiological responses to the hallucinogen were linked to an up-regulation of 5-HT2A receptors in the medial prefrontal cortex, while 5-HT2C and 5-HT1A receptors remained unchanged. These findings suggest that methamphetamine-induced changes in 5-HT2A receptor expression may contribute to psychosis-like behaviors and could inform therapies for methamphetamine-related psychiatric disorders.
Study at a glance
| Characteristics | Controlled experiment Peer reviewed |
|---|---|
| Population | ICR male mice |
| Intervention | Methamphetamine |
| Dose | 4 x 5 mg/kg |
| Duration | Single-day binge dosing at 2-hour intervals |
| Topics | Serotonin |
| Keywords | Prefrontal cortex Methamphetamine Psychology Agonist |
| Citations | 31 |
| Key finding | Methamphetamine binge exposure increased 5-HT2A receptor expression and decreased mGlu2 receptor expression in the medial prefrontal cortex, associated with enhanced behavioral and neural responses to a 5-HT2A/2C agonist. |
Abstract
The repeated administration of methamphetamine (MA) to animals in a single-day 'binge' dosing regimen produces damage to dopamine and serotonin terminals and psychosis-like behaviours similar to those observed in MA abusers. The present study aimed to examine the effects of MA binge exposure on 5-HT2A receptors, the subtype of serotonin receptors putatively involved in psychosis. ICR male mice were treated with MA (4 × 5 mg/kg) or saline at 2 h intervals. Recognition memory and social behaviours were sequentially evaluated by a novel location recognition test, a novel object recognition test, a social interaction and a nest-building test to confirm the persistent cognitive and behavioural impairments after this dosing regimen. Subsequently, a hallucinogenic 5-HT2A/2C receptor agonist 2,5-dimethoxy-4-iodoamphetamine (DOI)-induced head-twitch, molecular and electrophysiological responses were monitored. Finally, the levels of 5-HT2C, 5-HT1A, 5-HT2A and mGlu2 receptors in the medial prefrontal cortex were determined. MA binge exposure produced recognition memory impairment, reduced social behaviours, and increased DOI-induced head-twitch response, c-Fos and Egr-2 expression and field potentials in the medial prefrontal cortex. Furthermore, MA binge exposure increased 5-HT2A and decreased mGlu2 receptor expression in the medial frontal cortex, whereas 5-HT2C and 5-HT1A receptors were unaffected. These data reveal that the increased behavioural, molecular and electrophysiological responses to DOI might be associated with an up-regulation of 5-HT2A receptors in the medial prefrontal cortex after MA binge exposure. Identifying the biochemical alterations that parallel the behavioural changes in a mouse model of MA binge exposure may facilitate targeting therapies for treatment of MA-related psychiatric disorders.